Merck's Oral PCSK9 Inhibitor Could Pose A Future Threat After Early Trial Success

 
• By Jessica Merrill
  
pills versus injections
Merck's oral PCSK9 blocker shows similar efficacy to injections • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cardiovascular

More from Therapeutic Category